Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>News>This Article

Flu Sends Scientists Dipping for Gold

Published: Wednesday, December 11, 2013
Last Updated: Wednesday, December 11, 2013
Bookmark and Share
Researchers on the Norwich Research Park have patented a quick, simple dipstick flu test using sugar labelled with gold.

Quick diagnosis of flu is important because vaccination and antiviral drugs need to be administered to patients within 48 hours of infection to prevent new pandemics arising.

“We are now looking for a diagnostics company to help us bring it to market,” said Professor Rob Field from the John Innes Centre.

He and Professor David Russell from the University of East Anglia found that a gold solution changes colour in the presence of the flu virus. And the colour it changes to differs according to the strain of flu.

Results published in Organic & Biomolecular Chemistry show that gold nanoparticles can be used to detect the human influenza virus X31 (H3N2) within 30 minutes and to distinguish between human and avian influenza.

Prof Field explains that 90% of human infections use carbohydrate recognition to bind with targets in the body. The sensor is a suspension of sugars tagged with gold particles. If the flu virus is present, it will attach to a sugar, pulling particles closer together. Human and avian flu have a preference for different sugar chains resulting in a colour change visible to the naked eye.

“The same basic principles can be applied wherever rapid detection is required from detecting superbugs in hospitals to biohazards such as ricin,” said Professor Field.

The researchers have already developed a carbohydrate-based sensor to detect cholera in contaminated water supplies.

“Our technique based on gold nanoparticles is much faster than current methods of detection,” said Professor Russell from UEA.

Professor Russell leads a spinout company, Intelligent Fingerprinting, based on drug and drug metabolite screening using the sweat contained in fingerprints. Government funding is being used to develop a patented handheld device for use in Accident and Emergency and coroner services.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Biomedical Imaging at One-Thousandth the Cost
Mathematical modeling enables $100 depth sensor to approximate the measurements of a $100,000 piece of lab equipment.
Improving Outcomes for Lung Cancer and Diabetic Patients
Novel technologies have been developed with support from SBRI Healthcare funding.
New Way of Detecting Cancer
A new RNA test of blood platelets can be used to detect, classify and pinpoint the location of cancer by analysing a sample equivalent to one drop of blood.
Rapid, Portable Ebola Diagnostic
Scientists confirmed the efficiency of the novel Ebola detection method in field trials.
New, Better Test for Prostate Cancer
A study from Karolinska Institutet shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA.
Blood Test Picks Out Prostate Cancer Drug Resistance
Scientists have developed a blood test that can identify key mutations driving resistance to a widely used prostate cancer drug, and identify in advance patients who will not respond to treatment.
Antibody Targets Key Cancer Marker
University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine.
Key Piece of MRSA Vaccine Puzzle
New research funded by the Health Research Board and the Wellcome Trust has pinpointed immune cells that could be targeted by an MRSA vaccine.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos